Press release
Peptide Based Infection Therapeutics Market Value to reach US$ 1.5 Bn by 2022
The global peptide based infection therapeutics market is anticipated to show a value a shade less than US$ 1.5 Bn and expected to grow at a robust rate during the period of forecast.
6 Forecast Highlights on Global Peptide Based Infection Therapeutics Market
North America expected to show higher market attractiveness and domination over other regions in terms of market share by revenue. It has a higher value share and is poised to grow at a higher growth rate to reflect a CAGR of 8.4% throughout the forecast period, 2017 to 2022
Request For Report Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=188
Asia-Pacific excluding Japan (APEJ) shows the highest growth rate and poised to register a CAGR of 8.7% during the period of forecast, owing to rapid development and higher foreign direct investment in this region. Following APEJ, Europe region also reflects good rate of growth in the global peptide based infection therapeutics market
By drug class, telaprivir shows higher market share by revenue as compared to boceprevir. However, boceprivir shows a higher growth rate to reflect a CAGR of 8.2% during the period of forecast. It can be said that, even though telaprevir segment has a market share which is almost one and a half times than that of boceprevir, the boseprivir segment, could match the market share at this high growth rate post 2022, a market observation which would depend on the current growth rate of boceprivir and its consistency through 2017 to 2022 and even beyond
The online pharmacies segment by distribution channel shows the fastest growth rate and is poised to reflect a CAGR of 9.2% throughout the period of forecast of 2017 to 2022. Yet, this segment shows less market share by revenue as compared to other segments.
Request For Discount: https://www.factmr.com/connectus/sample?flag=D&rep_id=188
The hospital pharmacy segment enjoys the highest market revenue share followed by retail pharmacy segment. The retail pharmacy segment, however, reflects a higher growth rate as compared to the hospital pharmacy segment. It would be only appropriate to track these two segments who have a toe to toe competition, in order to check the scenarios by the end of 2022
The online pharmacies segment finds North America region to be the most lucrative and has the highest growth in this region comparatively. The APEJ region is much favorable for the hospital and retail pharmacies segment followed by Europe. Latin America and Middle East and Africa region show less attractiveness comparatively
The report has also profiled leading players in the global market for peptide based infection therapeutics, which would remain active through 2022. These include companies like Parchem Fine & Specialty Chemicals, Merck & Co., Inc. and Vertex Pharmaceuticals Incorporated.
Browse Full Report: https://www.factmr.com/report/188/peptide-based-infection-therapeutics-market
ABOUT US:
Fact.MR is focused on offering transformative intelligence that inspires breakthroughs and innovation. We believe that the right decisions at the opportune time are integral to achieve extraordinary success. We are here to help you with your strategic decision making.
CONTACT:
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Phone: +353-1-6111-593
Email: sales@factmr.com
Website: https://www.factmr.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Based Infection Therapeutics Market Value to reach US$ 1.5 Bn by 2022 here
News-ID: 686046 • Views: …
More Releases from Fact.MR
Organic Rice Syrup Market is forecasted to increase at a CAGR of 5.1% and US$ 1. …
The global Organic Rice Syrup Market is projected to expand steadily over the coming decade, driven by rising consumer demand for natural, clean-label sweeteners and growing awareness of health and wellness trends. Industry analysts estimate that the organic rice syrup market, valued at approximately USD 450 million in 2025, is expected to reach nearly USD 880 million by 2035, registering a compound annual growth rate (CAGR) of about 7.1% during…
Compound Horse Feedstuff Market is Estimated to Grow at a CAGR of 4.6%, Reaching …
The global compound horse feedstuff market is galloping toward steady growth, projected to expand from a valuation of USD 3.8 billion in 2026 to approximately USD 5.4 billion by 2036. This represents a compound annual growth rate (CAGR) of 3.6% over the ten-year forecast period.
The market is being driven by the "humanization" of equine companions, the professionalization of equestrian sports, and a significant shift toward specialized performance nutrition that…
Nutritional Yeast Market Forecasted CAGR is 7.1% by 2035 | Fact.MR Report
The global nutritional yeast market is experiencing a significant surge in demand, projected to grow from a valuation of USD 515.2 million in 2026 to approximately USD 1.2 billion by 2036. This represents a robust compound annual growth rate (CAGR) of 8.8% over the ten-year forecast period.
The market is being propelled by the global explosion of plant-based diets and the "clean-label" movement, with nutritional yeast emerging as the primary…
Dairy Stabilizer Market is Expected to Reach USD 1,420.0 million by 2035 | Resea …
The global Dairy Stabilizers Market is projected to sustain solid growth over the next decade as consumer demand for high-quality dairy and dairy-based products continues to expand across foodservice and retail sectors. Industry analysts estimate that the dairy stabilizers market, valued at approximately USD 2.4 billion in 2025, is expected to reach around USD 4.3 billion by 2035, registering a compound annual growth rate (CAGR) of about 6.5% during the…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
